AYTU BIOPHARMA, INC Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AYTU BIOPHARMA, INC stock issued during period, value, other for the quarter ending 2018-12-31 was $11.69K, a 95.10% decline year-over-year.
- AYTU BIOPHARMA, INC stock issued during period, value, other for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC stock issued during period, value, other for the quarter ending 2018-03-31 was $0.00.
- AYTU BIOPHARMA, INC stock issued during period, value, other for the quarter ending 2017-12-31 was $238.41K.
- AYTU BIOPHARMA, INC stock issued during period, value, other for fiscal 2019 was $11.69K, a 95.32% decline from fiscal 2018.
- AYTU BIOPHARMA, INC stock issued during period, value, other for fiscal 2018 was $250.00K, a 87.05% decline from fiscal 2017.
- AYTU BIOPHARMA, INC stock issued during period, value, other for fiscal 2017 was $1.93M.
- AYTU BIOPHARMA, INC stock issued during period, value, other for fiscal 2011 was $37.50K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2019-06-30 | $11.69K 10-K · filed 2020-10-06 | |
| 2018-12-31 | $11.69K 10-Q · filed 2020-05-15 | |
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | $250.00K 10-K · filed 2018-09-06 |
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $270.41K derived: sum of 4 quarters · filed 2018-05-14 |
| 2017-12-31 | $238.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | |
| 2017-09-30 | $11.59K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $20.41K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $1.93M 10-K · filed 2017-08-31 |
| 2011-08-31 | $37.50K 10-K · filed 2014-11-26 | |
| 2006-08-31 | $28.00K 10-K · filed 2014-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |